Atlas Trials

The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients

Clinical trial NCT02443194 · TERMINATED

Trial details

NCT number
NCT02443194
Sponsor
michal roll
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Depression
Start date
2015-05-01
Primary completion
2015-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.